Hans van Dijk
Chief Operating Officer at Julius Clinical Research BV
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Erik Bosman | M | - |
Julius Clinical Research BV
Julius Clinical Research BV Miscellaneous Commercial ServicesCommercial Services Julius Clinical Research BV is a scientifically focused CRO that provides end-to-end clinical trial services to pharmaceutical and biotechnology customers, governments, and academia. The private company is based in the Netherlands and was founded in 2008. Julius Clinical's renowned scientific leaders are at the forefront of their fields, which combine with operational excellence and a network of research sites to deliver tailor-made solutions for customers and their clinical trials. The Dutch company has approximately 200 employees and has supported over 130 clinical trials, enrolling more than 200,000 participants in around 40 countries. Julius Clinical has a focus on the therapeutic areas of neurology, renal, cardiometabolic, and infectious diseases. The company uses its unique triangle of science, networks, and operations to provide tailored CRO and SMO services. Martijn Wallert has been the CEO of the company since 2021. | 3 years |
Martijn Wallert | M | - |
Julius Clinical Research BV
Julius Clinical Research BV Miscellaneous Commercial ServicesCommercial Services Julius Clinical Research BV is a scientifically focused CRO that provides end-to-end clinical trial services to pharmaceutical and biotechnology customers, governments, and academia. The private company is based in the Netherlands and was founded in 2008. Julius Clinical's renowned scientific leaders are at the forefront of their fields, which combine with operational excellence and a network of research sites to deliver tailor-made solutions for customers and their clinical trials. The Dutch company has approximately 200 employees and has supported over 130 clinical trials, enrolling more than 200,000 participants in around 40 countries. Julius Clinical has a focus on the therapeutic areas of neurology, renal, cardiometabolic, and infectious diseases. The company uses its unique triangle of science, networks, and operations to provide tailored CRO and SMO services. Martijn Wallert has been the CEO of the company since 2021. | 3 years |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Netherlands | 2 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Hans van Dijk
- Personal Network